Yogic Breathing Instruction in Patients with Treatment-Resistant Generalized Anxiety Disorder: Pilot Study.

Anxiety disorder generalized anxiety disorder pranayama yogic breathing

Journal

International journal of yoga
ISSN: 0973-6131
Titre abrégé: Int J Yoga
Pays: India
ID NLM: 101313247

Informations de publication

Date de publication:
Historique:
entrez: 30 1 2019
pubmed: 30 1 2019
medline: 30 1 2019
Statut: ppublish

Résumé

This study aims to evaluate the feasibility and effects of instruction in yogic breathing techniques ( Participants were adult primary or secondary care patients with a primary diagnosis of GAD (with or without comorbidity) and persistent anxiety symptoms of at least moderate intensity, despite prior treatment with two or more medications of proven efficacy. Patients participated in group-delivered yogic breathing training and practice for 12 weeks. Structured assessments were performed at baseline, after 1, 2, and 6 weeks of instruction, and at end-point. Participants also completed the antisaccade (emotional variant) task and startle response task at baseline and end-point. At baseline, participating patients ( The absence of a control group and small sample size. Yogic breathing techniques proved simple to learn and may be beneficial in reducing anxiety and depressive symptoms in patients with treatment-resistant GAD. Yogic breathing had no effect on autonomic arousal, but the reduction in errors to negative stimuli in the antisaccade task suggests an improvement in attention control during the intervention accompanying the reduction in symptoms.

Identifiants

pubmed: 30692788
doi: 10.4103/ijoy.IJOY_22_18
pii: IJY-12-78
pmc: PMC6329222
doi:

Types de publication

Journal Article

Langues

eng

Pagination

78-83

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

J Affect Disord. 2000 Dec;61(3):137-59
pubmed: 11163418
Int J Psychophysiol. 2002 Sep;45(3):261-5
pubmed: 12208533
Br J Med Psychol. 1959;32(1):50-5
pubmed: 13638508
J Exp Psychol. 1951 May;41(5):317-28
pubmed: 14861383
J Altern Complement Med. 2005 Feb;11(1):189-201
pubmed: 15750381
Eur Neuropsychopharmacol. 2005 Aug;15(4):357-76
pubmed: 15961293
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
pubmed: 21896369
Hum Psychopharmacol. 2013 May;28(3):274-80
pubmed: 23653434
J Psychopharmacol. 2014 Sep;28(9):874-80
pubmed: 24899597
J Psychiatr Res. 2015 Apr;63:117-22
pubmed: 25765144
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538

Auteurs

Nupur Tiwari (N)

Southern Health NHS Foundation Trust, Faculty of Medicine, University of Southampton, UK.
Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK.

Michelle Sutton (M)

Southern Health NHS Foundation Trust, Faculty of Medicine, University of Southampton, UK.

Matthew Garner (M)

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK.
Department of Psychology, Faculty of Social, Human and Mathematical Sciences, University of Southampton, UK.

David S Baldwin (DS)

Southern Health NHS Foundation Trust, Faculty of Medicine, University of Southampton, UK.
Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, UK.

Classifications MeSH